First, we observed no significant changes in the stroma fraction, cytolytic activity, and PD-1 expression between CNA versus control subgroups in all inquired tumor samples; however, IFNG, GZMA and PD-L1 expression were elevated in mutant (CNA) cancers (Figure S3). The gene discussed is CD274; the disease is neoplasm.